U.S. Healthtech Stock News

If you are wondering whether Energizer Holdings at around US$19.69 is a bargain or a value trap, this breakdown will help you frame the price against what the business may be worth. The stock has been volatile, with a 15.8% gain over the last 30 days coming after a 23.4% decline over the past year and a 52.1% decline over five years. These moves can change how the market views both its potential and its risks. Recent coverage has largely focused on the share price slide over the past few...

Enterprise Products Partners (NYSE:EPD) reports record operating volumes linked to the ongoing closure of the Strait of Hormuz. The disruption to global energy flows is associated with a substantial boost to the company’s earnings and EBITDA in Q1 2026. Management outlines revised growth plans, capital allocation priorities, and the role of recently commissioned assets in responding to this supply shock. The company’s latest expansion projects influence expectations for North American energy...

Considering whether Trane Technologies at around US$480 per share still offers value, or if most of the upside is already reflected in the price. The stock has been steady over the last week with a 0.3% return, while the 30 day, year to date, 1 year and 3 year returns of 17.2%, 20.8%, 37.3% and 163.7% provide a strong backdrop for any valuation check. Recent coverage has focused on Trane Technologies as a key player in building-related equipment and services, with attention on how its market...

Why Telesat (TSAT) is back on investor radars Telesat (NasdaqGS:TSAT) has drawn fresh attention after a sharp move in its share price, with the stock showing a 36% gain over the past month and 52% over the past 3 months. See our latest analysis for Telesat. That recent surge sits within a much bigger move, with a year to date share price return of 56.93% and a 1 year total shareholder return of 195.80%. The 3 year total shareholder return is a very large multiple of the starting point,...

Noble (NE) shares are in focus after first quarter results combined higher net income with new contract awards of about US$565 million, a reaffirmed US$0.50 quarterly dividend, and maintained full year guidance. See our latest analysis for Noble. These earnings, contract wins and the reaffirmed dividend come after a strong run, with a 47.3% 90 day share price return and a 141.5% 1 year total shareholder return. This suggests momentum has been building despite a recent 4.9% 1 day pullback to...

AST SpaceMobile (ASTS) is back in focus after the Federal Communications Commission approved its request to modify authorization for the SpaceMobile non geostationary satellite system, clearing the way for up to 248 low Earth orbit satellites. See our latest analysis for AST SpaceMobile. Despite the FCC approval and a steady stream of launch related updates, the share price has recently pulled back, with a 1 day share price return of 6.89% decline and a 90 day share price return of 40.71%...

If you are wondering whether Getty Realty's current share price still offers value or if most of the opportunity is already priced in, this breakdown focuses squarely on what you are paying for versus what you are getting. The stock closed at US$33.14, with a 30 day return of 4.4%, a 1 year return of 27.0% and a 5 year return of 40.3%, which will naturally shape how investors think about both upside potential and downside risk. Recent moves sit against a backdrop of ongoing interest in...

Oshkosh Defense, a segment of NYSE:OSK, unveiled advanced military mobility solutions at Modern Day Marine 2026. The company highlighted new capabilities that support naval campaigns, including the ROGUE-Fires system and an enhanced Medium Tactical Vehicle Replacement (MTVR) 4x4. The event spotlighted Oshkosh Defense's focus on mobility and sustainment solutions for modern military requirements. For investors watching NYSE:OSK, this update sits at the core of Oshkosh's defense and specialty...

Stock performance snapshot and trigger context Erasca (ERAS) has drawn attention after recent trading left the stock with a 1 day return of about 0.5% and a 7 day decline of roughly 0.5%, prompting a closer look at its clinical stage oncology profile. See our latest analysis for Erasca. The recent 1 day share price return of about negative 48% and 7 day share price return of roughly negative 54% sit against a much stronger year to date share price return of about 176% and a very large 1 year...

US Nuclear Regulatory Commission finalized its technology inclusive Part 53 licensing rule, targeting advanced reactors. The NRC also proposed a new Part 57 framework focused on microreactor licensing. These actions directly affect the commercialization path for NANO Nuclear Energy's KRONOS MMR microreactor. The changes are relevant for investors watching regulatory risk and deployment timelines for NasdaqCM:NNE. NANO Nuclear Energy, listed as NasdaqCM:NNE, is working to bring its KRONOS...

Why Ingevity Might Be On Your Radar Now Ingevity (NGVT) has drawn attention recently as investors reassess the business after a period in which the stock has moved differently over the past month and past three months compared with its longer-term record. See our latest analysis for Ingevity. The current share price of $74.74 sits against a 1 month share price return of 5.91% and a year to date share price return of 24.38%. The 1 year total shareholder return of 126.28% contrasts with a 5...

In recent days, Deckers Outdoor has moved lower while analysts have been projecting upcoming quarterly earnings per share of $0.81 and revenue growth of 5.9% from the prior-year period. This combination of softer earnings expectations and continued revenue expansion is sharpening attention on how the company balances profitability with growth ahead of its results. We’ll now explore how this anticipated earnings softness, alongside revenue growth, may influence Deckers Outdoor’s longer-term...

Itron (ITRI) opened 2026 with Q1 revenue of US$587 million and basic EPS of US$1.20, alongside trailing twelve month revenue of US$2.35 billion and EPS of US$6.37 that frame the latest quarter within a solid run of reported profitability. Over recent periods, the company has seen quarterly revenue track between US$572 million and US$613 million and basic EPS range from US$1.29 to US$2.25. Trailing net income and EPS have moved from US$239 million and US$5.27 a year earlier to US$289 million...

Ulta Beauty: key recent performance signals Ulta Beauty (ULTA) has seen its share price move in different directions over shorter and longer periods, including a small 1 day decline, a weaker past week, and a gain over the past month. See our latest analysis for Ulta Beauty. At a share price of US$538.15, Ulta Beauty has seen short term momentum cool, with a 7 day share price return of 4.57% and a 90 day share price return of 14.73%, while the 1 year total shareholder return of 36.02% points...

USA Rare Earth (NasdaqGM:USAR) agreed to acquire Serra Verde Group in a transaction valued at about US$2.8b. The deal brings the Pela Ema mine in Brazil and a fully integrated mine and processing hub under USAR’s control. The acquisition includes a 15-year offtake agreement with price floors and new financing commitments. The transaction is positioned to expand USAR’s scale, supply chain security outside Asia, and production capabilities. For investors tracking rare earths, USA Rare Earth...

Why Stryker (SYK) Is On Investors’ Radar Now Stryker (SYK) has drawn fresh attention after recent trading, with the share price around $321.43 and a mixed return profile over the past month and past 3 months prompting closer portfolio reviews. See our latest analysis for Stryker. Recent trading has been softer, with a 90 day share price return of a 10.17% decline and a 1 year total shareholder return of a 12.51% decline. This contrasts with positive 3 and 5 year total shareholder returns and...

In April 2026, Mundipharma and Melinta Therapeutics, a wholly owned subsidiary of CorMedix, reported positive Phase III topline results from the global ReSPECT trial, showing once-weekly REZZAYO prophylaxis was non-inferior to standard regimens for preventing invasive fungal diseases in adults undergoing allogeneic stem cell transplants, with a favorable safety profile. This outcome strengthens the case for a potential REZZAYO label expansion in a high-risk transplant setting where long-term...

What Broadridge Financial Solutions Means For Investors Right Now Broadridge Financial Solutions (BR) has drawn investor attention after a period of mixed share performance, including a sharp negative total return over the past year alongside positive multiyear gains and ongoing revenue and net income growth. See our latest analysis for Broadridge Financial Solutions. At a share price of US$158.83, Broadridge Financial Solutions has seen a sharp 90 day share price return of negative 22.48%...

Comments from the Commodity Futures Trading Commission about upcoming prediction market rules, including possible limits on prop bets and parlays, pushed Flutter Entertainment (NYSE:FLUT) shares up 1%. This highlights how regulatory shifts can quickly reshape sentiment. See our latest analysis for Flutter Entertainment. That regulatory update lands against a mixed share price backdrop, with a 30 day share price return of 8.55% contrasting with a 90 day share price return of 34.57% and a year...

If you are asking whether CNX Resources at around US$39 per share still offers value or is starting to look expensive, the next sections will walk through what the current valuation actually reflects. The stock has returned 3.4% over the past week, moved by 3.5% over the last month, is up 7.4% year to date, and has returned 32.6% over the past year and 164.1% over three years. These shifts can change how the market is pricing future expectations and risk. Recent coverage has focused on CNX...

Centene (CNC) has opened 2026 with Q1 revenue of US$49.9b and basic EPS of US$3.13, setting a clear marker after a volatile run of quarterly earnings. Over recent periods, revenue has moved from US$43.3b in Q1 2025 to US$45.1b in Q4 2025 and now US$49.9b in Q1 2026. Basic EPS has swung from US$2.64 to losses of US$0.51, US$13.50 and US$2.24 per share before returning to a profit of US$3.13 per share in the latest quarter. For investors, that combination of large revenue, sharp EPS swings and...

Why BellRing Brands is Back in Focus Reports of unusual volatility across consumer staples in 2026 have put BellRing Brands (BRBR) on traders’ radar, as investors reassess how “defensive” the sector really looks right now. See our latest analysis for BellRing Brands. BellRing’s recent 10.29% 1-month share price return, following a 2.92% 7-day gain, sits against a 35.11% decline year to date and a 77.94% drop in 1-year total shareholder return. This suggests that short-term momentum is...

Why ESAB (ESAB) Is Drawing Investor Attention Now ESAB (ESAB) is back on watch for investors after a mixed run, with a roughly 9% gain over the past month in contrast to negative moves over the past year and over the past 3 months. See our latest analysis for ESAB. With the share price now at $99.53, the recent 8.7% one-month share price return contrasts with a weaker year-to-date share price return and a one-year total shareholder return of around a 16% decline, while the three-year total...

With inflation expectations lifting, central banks still signaling tight policy and energy prices adding fresh uncertainty, investors are again paying close attention to quality and resilience. The High Quality Undervalued Stocks screener focuses on companies with strong cash generation and solid balance sheets that the market may be mispricing. That combination can help you stay grounded when yields are shifting and growth signals are mixed across regions. In this article, you will see 3...